Why Is Adobe Stock Dropping?
Why is Adobe stock dropping? A combination of underwhelming fiscal…
Buy
74
PEN Quote, Financials, Valuation and Earnings
Last price:
$237.21
Seasonality move
:
9.03%
Day range:
$236.62 - $241.89
52-week range:
$148.00 - $277.34
Dividend yield:
0%
P/E ratio:
276.14x
P/S ratio:
7.99x
P/B ratio:
8.25x
Volume:
189.8K
Avg. volume:
307.3K
1-year change:
-5.59%
Market cap:
$9.1B
Revenue:
$1.1B
EPS (TTM):
$0.86
Analysts' Opinion
-
Consensus RatingPenumbra has received a consensus rating of Buy. The company's average rating is a Buy based on 11 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $254.60, Penumbra has an estimated upside of 9.23% from its current price of $237.48.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $230.00 representing 100% downside risk from its current price of $237.48.
Fair Value
-
According to the consensus of 15 analysts, Penumbra has 9.23% upside to fair value with a price target of $254.60 per share.
PEN vs. S&P 500
-
Over the past 5 trading days, Penumbra has overperformed the S&P 500 by 1.34% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Penumbra does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Penumbra has grown year-over-year revenues for 17 quarters straight. In the most recent quarter Penumbra reported revenues of $301M.
Earnings Growth
-
Penumbra has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Penumbra reported earnings per share of $0.75.
Enterprise value:
8.8B
EV / Invested capital:
--
Price / LTM sales:
7.99x
EV / EBIT:
664.45x
EV / Revenue:
7.58x
PEG ratio (5yr expected):
0.06x
EV / Free cash flow:
65.76x
Price / Operating cash flow:
69.32x
Enterprise value / EBITDA:
222.63x
Gross Profit (TTM):
$731.3M
Return On Assets:
2.27%
Net Income Margin (TTM):
2.97%
Return On Equity:
3%
Return On Invested Capital:
3%
Operating Margin:
11.75%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $829.9M | $995.1M | $1.2B | $270.9M | $301M | |
| Gross Profit | $522.2M | $634.1M | $731.3M | $177.7M | $200.3M | |
| Operating Income | -$38.8M | $61.6M | $78.5M | $30.8M | $35.4M | |
| EBITDA | -$16.2M | $72.8M | $39.6M | $20.7M | $44.3M | |
| Diluted EPS | -$0.82 | $1.03 | $0.86 | $0.23 | $0.75 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $590.2M | $668M | $723.6M | $868.5M | $891.8M | |
| Total Assets | $810.3M | $973.2M | $1.3B | $1.5B | $1.5B | |
| Current Liabilities | $108.1M | $116.1M | $138.3M | $145.1M | $153.2M | |
| Total Liabilities | $190.6M | $288.6M | $347.8M | $364.2M | $374.8M | |
| Total Equity | $619.7M | $684.6M | $973.8M | $1.1B | $1.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$66.3M | $62.4M | $153.6M | $30.8M | $56.5M | |
| Cash From Investing | $44.8M | -$31.7M | $112.9M | -$44.4M | $35.7M | |
| Cash From Financing | $8.8M | $16M | -$87.2M | $212K | -$100.6M | |
| Free Cash Flow | -$90.1M | $47.3M | $134.2M | $27.5M | $51M | |
PEN
Sector
Market Cap
$9.1B
$47.7M
Price % of 52-Week High
85.63%
46.05%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-5.59%
-33.33%
Beta (5-Year)
0.521
0.760
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$240.38
200-day SMA
Buy
Level
$206.47
Bollinger Bands (100)
Buy
Level
192.14 - 238.36
Chaikin Money Flow
Buy
Level
35.2M
20-day SMA
Sell
Level
$243.28
Relative Strength Index (RSI14)
Sell
Level
46.11
ADX Line
Sell
Level
38.85
Williams %R
Buy
Level
-88.1472
50-day SMA
Buy
Level
$235.29
MACD (12, 26)
Buy
Level
0.68
25-day Aroon Oscillator
Sell
Level
-48
On Balance Volume
Neutral
Level
31M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (17.0338)
Buy
CA Score
(Annual)
Level (1.1896)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-2.9477)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
Stock Forecast FAQ
In the current month, PEN has received 11 Buy ratings 4 Hold ratings, and 0 Sell ratings. The PEN average analyst price target in the past 3 months is $254.60.
-
Where Will Penumbra Stock Be In 1 Year?
According to analysts, the consensus estimate is that Penumbra share price will rise to $254.60 per share over the next 12 months.
-
What Do Analysts Say About Penumbra?
Analysts are divided on their view about Penumbra share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Penumbra is a Sell and believe this share price will drop from its current level to $230.00.
-
What Is Penumbra's Price Target?
The price target for Penumbra over the next 1-year time period is forecast to be $254.60 according to 15 Wall Street analysts, 11 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is PEN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Penumbra is a Buy. 11 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PEN?
You can purchase shares of Penumbra via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Penumbra shares.
-
What Is The Penumbra Share Price Today?
Penumbra was last trading at $237.21 per share. This represents the most recent stock quote for Penumbra. Yesterday, Penumbra closed at $237.48 per share.
-
How To Buy Penumbra Stock Online?
In order to purchase Penumbra stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is 3M Stock Going Up?
After a decade-long slump in new product introductions, the leading…
Is It Time for Costco to Split?
Costco’s stock price has experienced enormous growth over the last…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 41x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
77
FTAI alert for Jan 1
FTAI Aviation [FTAI] is up 13.87% over the past day.
Buy
56
QMCO alert for Jan 1
Quantum [QMCO] is down 13.43% over the past day.
Buy
60
ARQQ alert for Jan 1
Arqit Quantum [ARQQ] is down 10.6% over the past day.
